CytoDyn Inc.
Extract: Update, Proxy Fight Director Nomination from a DFAN14A on 09/02/2021   Download
SEC Document
SEC Filing

The participants named herein (collectively, the “Participants”), have filed a definitive proxy statement and accompanying WHITE proxy card with the Securities and Exchange Commission to be used to solicit votes for the election of its slate of director nominees at the 2021 annual meeting of stockholders of CytoDyn Inc., a Delaware corporation (the “Company”).







On September 2, 2021, the Participants sent a letter to the Company’s stockholders (the “Stockholder Letter”) and posted the Stockholder Letter to their website, A copy of the Stockholder Letter is filed as Exhibit 1 hereto. Also on September 2, 2021, the Participants issued a press release announcing that they had sent the Stockholder Letter and detailing some of its contents. The press release contained a link to the Stockholder Letter. A copy of the press release is filed as Exhibit 2 hereto. The Participants also e-mailed links to the Stockholder Letter and the Press Release to certain of the Company’s Stockholders. A copy of the e-mail is filed herewith as Exhibit 3.